Winston Kung - Aug 16, 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role: Director
Signature: /s/ Meghan Houghton, attorney-in-fact for Winston Kung
Stock symbol: CRBP
Transactions as of: Aug 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/20/2024, 04:48 PM
Previous filing: Jun 28, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRBP	Common Stock, par value $0.0001 per share	Award	$0	+5.57K		$0.00	5.57K	Aug 16, 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRBP	Stock options (right to buy)	Award	$0	+5.57K		$0.00	5.57K	Aug 16, 2024	Common Stock	5.57K	$53.52	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 16, 2024, 5,566 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
F2	This amount includes 5,566 unvested RSUs that were granted on August 16, 2024 and will vest 100% on the one-year anniversary from the date of grant.
F3	The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.